Global Anti Counterfeit Packaging Technologies Market For Food and Pharmaceuticals (2009-2014)

Counterfeiting was earlier a problem specific to developing countries of Africa and Asia. However, with the recent increase in parallel trading and internet pharmacies, the industry has also expanded in developed nations such as the U.S. and Europe. Counterfeit medicines in particular are on the increase. The most commonly counterfeited drugs in developed countries are the so-called ‘lifestyle drugs’ and other common pharmaceuticals that have a high demand, such as aspirin, antacid, and analgesics.

Order Now

More Information

Tell-a-Friend

Pharmacovigilance Report and Analysis 2009: Present Challenges and Future Goals

Pharmacovigilance has been expanding in recent years, as companies are required to monitor drug safety post launch. Drug safety issues, such as those raised by Vioxx earlier this decade, have led to increased risk-averseness by regulators, with greater post-marketing assessment of drugs. Many regulatory agencies require detailed pharmacovigilance, with companies bearing extra costs, our new report also observes. Healthcare payers, prescribers and patients have high expectations from pharmacovigilance. They want thorough information - on adverse reactions and overall drug safety - upon which to make informed judgements. Pharmacovigilance is now being called upon to produce clear results, expressed openly. What will those trends mean for pharmacovigilance, from the perspectives of major stakeholders, including the pharma and biotech industries? Where is pharmacovigilance heading? What regulatory measures will continue, and which new processes will emerge? This new report - Pharmacovigilance 2009: Present Challenges and Future Goals - explains how that field will develop from the present onwards.

Order Now

More Information

Tell-a-Friend